Mayo Clinic’s Dr. Loprinzi to Speak on Scrambler Therapy to Treat Chronic Pain
West Linn, Ore. – January 27, 2015 – Radiant Pain Relief Centres welcomes Dr. Charles Loprinzi from the Mayo Clinic to the Portland Metropolitan area on Thursday, February 5 from 6 to 9 PM at Stafford Hills Club, 5916 Southwest Nyberg Lane, Tualatin. Dr. Loprinzi will address research, experience and findings on the use of artificial intelligence and neuroplasticity in the form of scrambler therapy to create lasting pain relief. He will focus specifically upon chemotherapy-induced neuropathy and back pain.
Scrambler therapy is a revolutionary new treatment for chronic neuropathic pain. Cleared by the FDA in 2009, it is non-invasive, non-pharmacological, side-effect free and effective at creating complete to near complete pain relief which lasts an average of 30-90 days in most chronic pain cases. West Linn-based Radiant Health Management Corp holds exclusive North American rights to the technology that most effectively delivers the treatment, and plans to open 100 Radiant Pain Relief Centres over the next five years.
CALENDAR LISTING DETAILS
WHO: Physicians, nurses, educators and other medical professionals
WHAT: “The Future of chronic pain treatment, using artificial intelligence and neuroplasticity to create lasting pain relief”
A presentation on scrambler therapy, a revolutionary new treatment for chronic neuropathic pain, which is non-invasive, non-pharmacological, side-effect free and effective at creating complete, or near complete, pain relief which lasts an average of 30-90 days in most chronic pain cases.
Guest Lecturer: Charles, Loprinzi, MD of Mayo Clinic, the leading research institution on srambler therapy in the US.
Presented by West Linn, OR-based Radiant Health Management Corporation, the exclusive rights holders for scrambler therapy in North America and the owner-operator of Radiant Pain Relief Centres, which use Scrambler Therapy within their highly refined, patient-centric care model to address the epidemic of chronic pain. Radiant opened its first of 100+ planned treatment centers in early 2014 in West Linn.
WHEN: Thursday, Feb 5th, 6-9pm (dinner will be served)
WHERE: Stafford Hills Club 5916 Southwest Nyberg Lane, Tualatin, OR 97062
WHY: Chronic pain affects 100 million people in the U.S. – more than cancer, diabetes and cardiovascular disease combined – at a cost of around $600 billion annually (direct cost of care & lost productivity). Chronic pain is defined as pain present for 3 months or longer, and typically has, or develops, some neuropathic or nerve-related pain. Sufferers generally have sought pain reduction from traditional treatments like drugs, injections and surgery, but remain in pain and seek another solution. This talk will address one of the newest and most promising solutions available.
HOW: Seating is limited, please RSVP to Brendon Lundberg, President/CEO of Radiant Health Management Corp at [email protected]
Methodology of Scrambler Therapy
The technology was developed in Italy by Professor Giuseppe Marineo at the Medical Bioengineering Research Center in Rome, and was cleared by the FDA in 2009 under the term “scrambler therapy.” It uses a new theory of pain management that addresses the way the brain receives and interprets chronic pain information, rather that trying to suppress or dull the pain message. By using artificial intelligence that mimics the body’s natural healthy pain signaling, the technology replaces the chronic pain message with a no pain message to the brain, which, through neuroplasticity, learns and adopts this new messaging. The result is significant or total pain relief for nearly all types chronic pain, lasting an average of 30-90 days.
About Chronic Pain and Treatment
More than 100 million people in the U.S. suffer from chronic pain, according to American Academy of Pain Medicine, or nearly one in three people. Historical treatment approaches for chronic pain are limited, and often risky, costly or come with significant side effects. In fact, the most recent data from the National Survey on Drug Use and Health (NSDUH) in September ranked Oregon number one in the U.S. for the non-medical use of opioids—an illegal and often risky and potentially lethal use of painkiller medications. The high rate of opioid use in Oregon is part of a nationwide trend over the last two decades. Radiant Pain Relief Centres are uniquely positioned to address the epidemic of chronic pain; without drugs, needles, or surgery.
To date, Radiant Pain Relief Centres have gathered the following patient data:
- Average Reduction in pain as a score, 6.2
- Average Reduction in pain as a percentage, 81%
- Percentage reduced to zero or one, 50%
- Average reduction in pain area (rule of 9s), 66%
- Average number of initial treatments, 10 sessions
- Average duration of relief, 30-90 days
- Average number of maintenance boosters, avg. 5 treatment per 6 patients
- Percentage of patient who pursue therapy, 84%
- Patient demographics, approx. 50% male and female
About Dr. Charles Loprinzi
Dr. Charles L. Loprinzi graduated from the Oregon Health & Science University School of Medicine in 1979. He is currently the Regis Professor of Breast Cancer Research at the Mayo Clinic, Rochester, Minn., emeritus chair of the Division of Medical Oncology and an emeritus Vice Chair of the Department of Oncology.
Dr. Loprinzi has run an active cancer control program directed toward both cancer prevention efforts and symptom control efforts, which has led to the publication of over 300 articles and book chapters. In addition, Dr. Loprinzi serves as the founding editor for the Art of Oncology section of the Journal of Clinical Oncology.
In addition, he edited an anthology of articles from the Art of Oncology series that was made available via the Kindle electronic book format, in the spring of 2010. Dr. Loprinzi’s work has led to him receiving two awards from the Susan B Komen Foundation, the Komen Foundation Brinker award in 2002 and the 2005 Komen Foundation Professor of Survivorship. In 2005, he was awarded the 2006 Clinical Research Award by the Association of Community Cancer Centers (ACCC). In 2006, he was awarded the North American Menopausal Society (NAMS) Vasomotor Symptoms Research Award.
About Radiant Pain Relief Centres
Radiant Pain Relief Centres are progressive, patient-centric care facilities that are effectively resolving the epidemic of chronic pain. Built around an exclusive FDA-cleared technology, Radiant Pain Relief Centres are able to create significant or total pain relief, which lasts an average of 30-90 days following therapy without drugs, needles, surgery or side effects. This exclusive technology uses the information theory to retrain the brain through neuroplasticity and return the body a more normal state of nervous system health and thereby achieve significant, lasting pain relief. This technology, along with a unique, highly-refined care model, make the Radiant Pain Relief Centre approach the most effective and appealing way to treat chronic pain. For more information visit www.radiantpainrelief.com
About Radiant Health Management Corp.
Radiant Health Management Corporation owns and runs progressive pain treatment centers built around an exclusive FDA-cleared therapy technology and a highly refined care model. Radiant Pain Relief Centres appeal to chronic pain suffers and their families because of an effective therapeutic and care solution that addresses epidemic of chronic pain. Therapy is non-invasive, non-pharmacological, produces no side effects and in most cases creates significant or total pain reduction for 30-90 days or longer following therapy. Radiant Health Management Corporation is based in West Linn, OR and can be found online at www.radianthealthmgmt.com